Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap109.87M
Enterprise Value85.03M
CRBP
(NASDAQ)Corbus Pharmaceuticals Holdings, Inc.
$8.25-- (--)
Loading... - Market loading
Corbus Pharmaceuticals Holdings (CRBP) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Book (mrq)0.87
Price/Tangible Book (mrq)0.87
Enterprise Value Ratios
EV-based valuation multiples
EV/Earnings-1.01
EV/EBITDA-0.99
EV/EBIT-1.03
EV/FCF-1.15
Stock Price
Current price, 52-week range, and moving averages
Current Price$8.25
1-Day Change0.92%
52-Week High$20.56
52-Week Low$6.72
52-Week Change-4.84%
YTD Change4.83%
1-Year Change2.87%
50-Day MA$9.39
200-Day MA$10.20
Avg Volume (30 day)602.91K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding13.32M
Book Value per Share$9.49
Net Cash per Share$1.87
FCF per Share$-5.53
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$41.00
Target Upside/Downside396.97%
Analyst ConsensusBuy
Analyst Count8
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-66.90%
Return on Assets (ttm)-58.50%
Return on Invested Capital (ttm)-64.46%
Return on Capital Employed (ttm)-65.56%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue0.00
Gross Profit-15.24M
Operating Income-89.84M
Pretax Income-84.53M
Net Income-84.53M
EBITDA-85.82M
EBIT-82.82M
Diluted EPS$-6.61
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-73.64M
Capital Expenditures13.00K
Free Cash Flow-73.65M
Growth Rates (YoY)
Year-over-year growth metrics
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)144.48M
Cash & Securities (mrq)26.05M
Net Cash (mrq)24.84M
Net Cash per Share$1.87
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)1.21M
Working Capital (mrq)125.43M
Total Equity (mrq)126.34M
Book Value per Share$9.49
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)7.92
Quick Ratio (mrq)7.92
Debt/Equity (mrq)0.01
Debt/EBITDA (ttm)0.97
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-76.94%
FCF Yield-67.04%
Buyback Yield-70.47%
Total Shareholder Yield-70.47%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-3.89
Piotroski F-Score2/9
Frequently Asked Questions About Corbus Pharmaceuticals Holdings Statistics
What are the key financial metrics for CRBP?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CRBP's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Corbus Pharmaceuticals Holdings is overvalued or undervalued.
How do I read CRBP's profitability ratios?
Corbus Pharmaceuticals Holdings's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CRBP's debt ratios indicate?
The financial health section shows Corbus Pharmaceuticals Holdings's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CRBP's dividend analysis?
The dividend section covers Corbus Pharmaceuticals Holdings's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.